Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline

Documenti analoghi

• Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice
  di: Anna L. Godfrey, et al.
  Pubblicazione: (2024)
• JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms
  di: Ana Isabel Giraldo-Rincón
  Pubblicazione: (2023)
• Mutaciones en JAK2, MPL y CALR en neoplasias mieloproliferativas: análisis de disociación de alta resolución
  di: Yanina Paola Videla
  Pubblicazione: (2017)
• Real‐world treatment patterns and outcomes in accelerated and blast‐phase myeloproliferative neoplasms: Insights from a large multi‐centre cohort analysis in the United Kingdom
  di: Alexandros Rampotas, et al.
  Pubblicazione: (2026)
• Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis
  di: Emeline Voirin, et al.
  Pubblicazione: (2024)